In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients
Anna M. Jermakowicz, Luz Clarita Ruiz, Jonathan Chu…·Nagi G. Ayad
This paper develops DrugSeq, a computational platform that predicts drug sensitivities in medulloblastoma subgroups, identifying subgroup-specific therapies and potential drug repositioning candidates.